FDA hosts a meeting to discuss Pifzer's COVID-19 vaccination on Monday

BALTIMORE — On Monday at 11 a.m., a group of health experts and state and local leaders will be holding a virtual meeting to discuss how the COVID-19 vaccines will be distributed in Maryland.

They plan to talk about the allocation phases of the vaccine; how it will be given to people; and the community’s response to receiving the vaccine.

A panel with the FDA will also meet on Thursday to discuss the emergency authorization use of Pfizer’s vaccine. Then they’ll meet next week to talk about Moderna’s vaccine.

Something the U.S. Secretary of Health and Human Services talked about Sunday on ABC’s "This Week" is the recommendation that frontline health care workers and long-term care residents be among the first to receive the vaccine. However, the CDC is also warning that there may not be enough doses to give to those designated as top priority.

Federal officials estimate about 40 million vaccines will be available, if the FDA decides to approve Moderna's and Pfizer's vaccines. Each person needs two doses to be vaccinated, which is only enough for 20 million people.

This is something that will likely be discussed at this virtual panel hearing later Monday morning.

This article will be updated throughout the day, so feel free to check back for additional information.